A Cell Surface Receptor Complex for Collagen Type I Recognizes the Arg-Gly-Asp Sequence
Overview
Authors
Affiliations
To isolate collagen-binding cell surface proteins, detergent extracts of surface-iodinated MG-63 human osteosarcoma cells were chromatographed on affinity matrices of either type I collagen-Sepharose or Sepharose carrying a collagen-like triple-helical peptide. The peptide was designed to be triple helical and to contain the sequence Arg-Gly-Asp, which has been implicated as the cell attachment site of fibronectin, vitronectin, fibrinogen, and von Willebrand factor, and is also present in type I collagen. Three radioactive polypeptides having apparent molecular masses of 250 kD, 70 kD, and 30 kD were distinguishable in that they showed affinity toward the collagen and collagen-like peptide affinity columns, and could be specifically eluted from these columns with a solution of an Arg-Gly-Asp-containing peptide, Gly-Arg-Gly-Asp-Thr-Pro. These collagen-binding polypeptides associated with phosphatidylcholine liposomes, and the resulting liposomes bound specifically to type I collagen or the collagen-like peptide but not to fibronectin or vitronectin or heat-denatured collagen. The binding of these liposomes to type I collagen could be inhibited with the peptide Gly-Arg-Gly-Asp-Thr-Pro and with EDTA, but not with a variant peptide Gly-Arg-Gly-Glu-Ser-Pro. We conclude from these data that these three polypeptides are membrane molecules that behave as a cell surface receptor (or receptor complex) for type I collagen by interacting with it through the Arg-Gly-Asp tripeptide adhesion signal. The lack of binding to denatured collagen suggests that the conformation of the Arg-Gly-Asp sequence is important in the recognition of collagen by the receptor complex.
Chokwattananuwat N, Suttapreyasri S Regen Biomater. 2024; 11:rbae030.
PMID: 38605851 PMC: 11009026. DOI: 10.1093/rb/rbae030.
Simorgh S, Brouki Milan P, Saadatmand M, Bagher Z, Gholipourmalekabadi M, Alizadeh R Materials (Basel). 2021; 14(14).
PMID: 34300827 PMC: 8306468. DOI: 10.3390/ma14143909.
Peptide-Based Strategies for Targeted Tumor Treatment and Imaging.
Ayo A, Laakkonen P Pharmaceutics. 2021; 13(4).
PMID: 33918106 PMC: 8065807. DOI: 10.3390/pharmaceutics13040481.
MMP proteolytic activity regulates cancer invasiveness by modulating integrins.
Das A, Monteiro M, Barai A, Kumar S, Sen S Sci Rep. 2017; 7(1):14219.
PMID: 29079818 PMC: 5660204. DOI: 10.1038/s41598-017-14340-w.
Kapp T, Rechenmacher F, Neubauer S, Maltsev O, Cavalcanti-Adam E, Zarka R Sci Rep. 2017; 7:39805.
PMID: 28074920 PMC: 5225454. DOI: 10.1038/srep39805.